Trans-arterial Embolization for the Treatment of Facet Pain Due to Facet Arthropathy

Recruiting N/A Interventional Study
Facet Joint Arthropathy Pain Osteoarthritis
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 85
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
40 (estimated)
Sponsor
Northwell Health · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This single-site, single-arm study evaluates the feasibility, safety, tolerability, and efficacy of trans-arterial embolization (TAE) using Embozene microparticles for treating facetogenic pain due to facet arthropathy (osteoarthritis of the facet joints) in the lumbar spine.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age 18-85 * Confirmed diagnosis of spinal facet arthropathy on MRI OR CT * Confirmed diagnosis of lumbosacral facetogenic pain based on diagnostic nerve blocks. * Failed medical management of pain. * Back pain persistent for at least 6 months * Pain worse than …
Contacts

Betsy Moclair

516-253-7753

bmoclair@northwell.edu

CONTACT